Related Experiment Video
Updated: May 10, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Heart rate: a global target for cardiovascular disease and therapy along the cardiovascular disease continuum
Florian Custodis1, Jan-Christian Reil, Ulrich Laufs
1Klinik für Innere Medizin III, Kardiologie, Angiologie und internistische Intensivmedizin, Universitätsklinikum des Saarlandes, 66421 Homburg, Saar, Germany.
Insights
Elevated heart rate predicts mortality in cardiovascular patients. Selective heart rate reduction with ivabradine offers a therapeutic option to mitigate cardiovascular disease progression and improve outcomes.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Elevated resting heart rate is a significant predictor of mortality in both general and cardiovascular patient populations.
- Increased heart rate exacerbates cardiovascular disease progression, from endothelial dysfunction to plaque rupture and end-stage disease.
Purpose of the Study:
- To explore heart rate as a therapeutic target in cardiovascular disease.
- To evaluate the role of selective heart rate reduction using ivabradine in managing coronary artery disease and heart failure.
Main Methods:
- Review of pharmacological interventions targeting heart rate.
- Focus on the mechanism of action of I(f) current inhibitors like ivabradine.
- Discussion of the prognostic significance of heart rate in cardiovascular disease.
Main Results:
- Heart rate is a modifiable risk factor across the cardiovascular disease continuum.
- Ivabradine selectively reduces heart rate by inhibiting the I(f) current, offering a targeted intervention.
- Evidence suggests a role for heart rate reduction in managing patients with coronary artery disease and heart failure.
Conclusions:
- Selective heart rate reduction is a promising therapeutic strategy for cardiovascular disease.
- Further interventional studies are needed to confirm the role of heart rate reduction in primary and secondary prevention of cardiovascular and cerebrovascular events.
Abstract:
Heart rate is a predictor of cardiovascular and all-cause mortality in the general population and in patients with cardiovascular disease. Increased resting heart rate multiplies risk and interferes at all stages of the cardiovascular disease continuum initiating from endothelial dysfunction and continuing via atherosclerotic lesion formation and plaque rupture to end-stage cardiovascular disease. As a therapeutic target, heart rate is accessible via numerous pharmacological interventions. The concept of selective heart rate reduction by the I(f) current inhibitor ivabradine provides an option to intervene effectively along the chain of events and to define the specific and prognostic role of heart rate for patients with coronary artery disease and heart failure. Future interventional studies will further clarify the significance of heart rate and targeted heart rate reduction for primary and secondary prevention in cardiovascular and cerebrovascular events.
Related Concept Videos
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Factors Influencing Heart Rate
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Regulation of Heart Rates
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with bradycardia...
Cardiomyopathy V: Interprofessional Care
